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Hippocampal neurogenesis is changed by brain injury. When neuroinflammation accompanies injury, activation of resident
microglial cells promotes the release of inflammatory cytokines and reactive oxygen/nitrogen species like nitric oxide (NO). In
these conditions, NO promotes proliferation of neural stem cells (NSC) in the hippocampus. However, little is known about the
role of NO in the survival and differentiation of newborn cells in the injured dentate gyrus. Here we investigated the role of NO
following seizures in the regulation of proliferation, migration, differentiation, and survival of NSC in the hippocampus using the
kainic acid (KA) induced seizuremousemodel.We show that NO increased the proliferation of NSC and the number of neuroblasts
following seizures but was detrimental to the survival of newborn neurons. NOwas also required for the maintenance of long-term
neuroinflammation. Taken together, our data show that NO positively contributes to the initial stages of neurogenesis following
seizures but compromises survival of newborn neurons.
1. Introduction
Neurogenesis, amultistep process that gives rise to functional
and integrated new nerve cells from self-renewal and mul-
tipotent neural stem cells (NSC) [1, 2], occurs throughout
adulthood in many animal species, including humans [3, 4].
Adult neurogenesis involves proliferation, migration, differ-
entiation and fate determination, survival, maturation, and
integration of newborn cells into the preexisting neuronal
network. Twomain areas are recognized as neurogenic niches
in the adult mammalian brain: the subventricular zone (SVZ)
of the lateral ventricles and the subgranular zone (SGZ) of
the dentate gyrus of hippocampus. Particularly in dentate
gyrus, new nerve cells are formed locally at the border
between the granular layer and the hilus (SGZ), migrate short
distances along the inner granular zone (IGZ), and extend
long axonal projections to the CA3 pyramidal cell layer of
the hippocampus [5, 6]. It has been shown that neurogenesis
can bemodulated by different physiological and environmen-
tal factors. Hormones, some growth factors, learning, exer-
cise, and antidepressants seem to activate and stimulate the
proliferation of NSC [7–9], while aging or inflammation has
the opposite effect [10–12].The neurogenic response to lesion
involves neuroinflammation that activates resident microglia
cells. In these conditions, microglia cells release inflamma-
tory cytokines and reactive oxygen and nitrogen species like
NO [13].
NO is a free radical gaseous molecule that results from
the conversion of L-arginine into L-citrulline, catalyzed by
the nitric oxide synthase family of enzymes. Particularly in
inflammatory conditions, the expression of the inducible
nitric oxide synthase (iNOS) is involved in the production of
high levels ofNO.NO is an important cellularmessengerwith
different cell targets, being involved in many physiological
mechanisms in cardiovascular, immunological, and nervous
systems [14]. During neurogenesis, particularly in the early
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stages, such as proliferation, the neurogenic response medi-
ated by NO depends on the pathophysiological state of the
tissue, source of NO, and time of exposure [15]. Despite the
intensive investigation on the effect of NO on the prolifera-
tion of NSC, there is a lack of information about the role of
NO in migration, differentiation, and survival on newborn
cells following brain injury.
In this work we investigated the role of NO from inflam-
matory origin in the regulation of hippocampal neurogenesis
after a brain insult. We analyzed the proliferation of NSC,
migration, differentiation, and survival of newborn cells
using a KA-induced seizure mouse model [16, 17]. We show
thatNO increased the proliferation of early-born cells, partic-
ularly in the SGZ, and the number of neuroblasts, following
status epilepticus (SE). Furthermore, NO was important for
the maintenance of long-term neuroinflammation, which
may be the leading cause to its detrimental effect on the
survival of newborn cells in the dentate gyrus. Taken together,
our data show that NO is a promising target for promoting
the proliferation and migration of NSC following seizures,
although its presence may compromises long-term survival
of newborn cells.
2. Materials and Methods
2.1. Materials. 5-Bromo-2󸀠-deoxyuridine (BrdU), normal
goat serum (NGS), paraformaldehyde (PFA), and Triton X-
100 were purchased from Sigma Chemical (St. Louis, MO,
USA). Mouse anti-neuronal nuclear (NeuN) andmouse anti-
glial fibrillary acid protein (GFAP) were purchased fromMil-
lipore (Billerica, MA). DAKO fluorescent mounting medium
was obtained from DakoCytomation (Glostrup, Denmark).
Rat anti-BrdU was obtained from Oxford Biotechnology and
doublecortin (C-18) (DCX) from Santa Cruz Biotechnology
(Dallas, Texas, USA). Rabbit anti-cleaved caspase-3 was
obtained from Cell Signaling (Danvers, MA, USA). Anti-rat
and anti-rabbit IgG conjugated with Alexa Fluor 488 and
anti-rat and anti-mouse IgG conjugated with Alexa Fluor 594
secondary antibodies were purchased fromMolecular Probes
(Invitrogen, Paisley, UK). Kainic acid was obtained from
Ocean Produce (Canada) and sodium thiopental from B.
Braun Melsungen (Germany).
2.2. Animals. Two-month-old C57BL/6J (iNOS+/+) mice or
B6.129P2-Nos2tm1Lau/J (iNOS−/−) male mice were obtained
from Charles River (Barcelona, Spain) or The Jackson
Laboratory (Bar Harbor, ME, USA), respectively. The ani-
mals were kept in animal facilities with food and water
ad libitum in a 12 : 12 light-dark cycle. The weight of the
animals varied between 18 and 26 g. All experiments were
performed in accordance with NIH and European guidelines
(86/609/EEC) for the care and use of laboratory animals.
Furthermore, the animals were housed in our licensed ani-
mal facility (International Animal Welfare Assurance num-
ber 520.000.000.2006). In addition, all the people working
with animals have received appropriate education (FELASA
course) as required by the Portuguese authorities. This study
is included in two projects approved and financed by the
Foundation for Science and Technology (FCT, Portugal,
PTDC/SAU-NEU/102612/2008 and PTDC/NEU-OSD/0473/
2012) that approved the animal experimentation described.
The animal experimentation board at the Center for Neuro-
sciences andCell Biology also approved the use of the animals
in this study.
2.3. Administration of Kainic Acid in Mice. KA was dissolved
in a sterile saline solution (0.9% NaCl in water) and injected
subcutaneously (25mg/kg), as previously described by our
group [15]. All animals that received KA developed grade
five seizures or higher according to 1972s Racine’s six-point
scale modified for mice [18]. In animals injected with saline
solution alone, no seizures were observed and were used as
controls. At least three animals survived in each experimental
group.
2.4. Assessment of NSC Proliferation by 5-Bromo-2󸀠-deoxyuri-
dine Incorporation. To assess proliferation of NSC, all ani-
mals treated with KA or saline solution were treated with
BrdU (intraperitoneal (i.p.) injections, 4 doses, 50mg/kg) 2
hours apart, in a total of 200mg/kg, up to 12 hours before
sacrificing the animals at different time points (Figure 1(a)).
In order to analyze distribution of NSC along dentate
gyrus, all animals were treated with BrdU (i.p. injections,
4 doses, 50mg/kg) every 12 hours, three and seven days
after KA or saline administration. Three weeks later, mice
were sacrificed (Figures 1(b) and 1(c)). In both experiments
mice were transcardially perfused with 0.9% NaCl followed
by 4% PFA in 0.01M phosphate buffer saline (PBS, 7.8mM
Na
2
HPO
4
⋅2H
2
O, 2.7mMNaH
2
PO
4
⋅H
2
O, 154mMNaCl, and
pH 7.2), following deep anesthesia with Eutasil (20% sodium
pentobarbital). Brains were removed and kept overnight in
4% PFA for further fixation and then dehydrated in 20%
sucrose/0.2M phosphate buffer (PB, 48mM NaH
2
PO
4
⋅H
2
O,
152mM Na
2
HPO
4
⋅2H
2
O, and pH 7.2), at 4∘C. Coronal
sections from the hippocampal region were cryosectioned
(30 𝜇m thick, in 8 series) and stored in an antifreeze solution
(0.05M PB, 30% ethylene glycol, and 30% glycerol), at 4∘C.
2.5. Immunohistochemistry. Free-floating coronal hippocam-
pal sections were processed for immunohistochemistry
against DCX or BrdU and NeuN, BrdU, and GFAP or BrdU
and cleaved caspase-3. Brain sections were treated with 1M
HCl for 20min at 65∘C, for DNA denaturation and then
blocked for 1 hour with 5% NGS in 0.25% Triton X-100
in 0.01 PBS. Slices were then incubated with the primary
antibodies, goat anti-DCX (1 : 400) or rat anti-BrdU (1 : 50)
andmouse anti-NeuN (1 : 200) ormouse anti-GFAP (1 : 7000)
or rabbit anti-cleaved caspase-3 (1 : 600), 48 h at 4∘C. After
rinsing with 0.25% Triton X-100 in PBS and with 2% block
solution (NGS), the sections were incubated with the corre-
spondent secondary antibodies (1 : 200), in 2% block solution
(NGS), for 2 h in the dark, at room temperature. After rinsing
with 0.25%TritonX-100 in PBS, the sections were kept in PBS
0.1M solution, at 4∘C, until setting in 2% gelatin-coated slides
with DAKO fluorescence mounting medium.
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Figure 1: Experimental protocol for assessment of NSC proliferation (a) and differentiation (b and c). (a) KA or saline solutions were
subcutaneously injected (25mg/kg). Intraperitoneal injections (i.p.) of BrdU (4 doses, 50mg/kg) were administrated every 2 hours, up to
12 hours before transcardiac perfusion (P). (b) Administration protocol of BrdU 3 days after SE. (c) Administration protocol of BrdU 7 days
after SE. Intraperitoneal injections (i.p.) of BrdU (4 doses, 50mg/kg) were administrated every 12 hours. Perfusions (P) were performed 3
weeks after BrdU treatment, following anesthesia.
2.6. Analysis of BrdU Incorporation. The distribution of the
newborn cells in the dentate gyrus was analyzed in SGZ, IGZ
and outer granular zone (OGZ) (Figure 2) and the numbers
of BrdU+ cells were counted in each zone using an epifluores-
cence microscope (20x objective, Axiovert 200, Zeiss, Jena,
Germany).
Images (0.73 𝜇m 𝑧-stacks) from 50 BrdU+ cells of each
brain were acquired in a laser scanning microscope LSM
510 META or LSM 710 (Zeiss, Jena, Germany) with Argon/2
(488 nm) and DPSS 561-10 (561 nm) lasers (63x oil-immer-
sion objective). Orthogonal projections in 𝑦-axis were per-
formed and counted the number of BrdU+/NeuN+ or
BrdU+/GFAP+ or BrdU+/Casp3+ cells were counted. The
percentage of cells which show colocalization of markers was
obtained by dividing the total number of BrdU+/NeuN+ or
BrdU+/GFAP+ or BrdU+/Casp3+ cells by 50 BrdU+ cells.
2.7. DCX and GFAP Immunoreactivity. DCX and GFAP
immunoreactive areas were analyzed using ImageJ software.
Snap imageswere acquired in a Zeiss Axioimager (Zeiss, Jena,
Germany) with a 20x objective. The threshold value was set
for each staining and the percentage of dark background area
wasmeasured, excludingmore anterior and posterior dentate
gyri.
OGZ
IGZ
SGZ
Figure 2: Schematic representation of the three zones of the dentate
gyrus: the subgranular zone (SGZ), inner granular zone (IGZ), and
outer granular zone (OGZ).The number of BrdU+ cells (green) was
counted in each zone.
2.8. Statistical Analysis. The data are expressed as means ±
SEM. Statistical significance was determined by using two-
factor analysis of variance (ANOVA), followed by post hoc
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Table 1: NO increased NSC proliferation following treatment with KA.
Days iNOS
+/+ saline iNOS+/+ KA iNOS−/− saline iNOS−/− KA
Mean SEM Mean SEM Mean SEM Mean SEM
1 16,82 0,91 9,39 1,04 11,31 2,86 7,72 1,43
2 23,13 1,31 33,23 1,86 12,10 1,33 13,35 3,87
3 24,45 1,77 63,36∗∗∗ 1,36 16,71 4,05 25,64 0,53
5 26,32 1,12 82,69∗∗∗ 5,87 15,58 0,96 18,36 1,99
7 21,60 0,49 82,45∗∗∗ 3,44 20,08 0,61 87,08### 8,39
14 21,71 1,77 37,48∗∗ 1,99 17,15 1,38 27,33 2,16
Evaluation of cell proliferation in the subgranular zone (SGZ) of iNOS+/+ versus iNOS−/− mice, at several time points after SE, assessed by BrdU incorporation.
Following seizure induction, there is a time-dependent increase in cell proliferation in iNOS+/+ animals, peaking at day 5. In iNOS−/− mice, only 7 days after
SE the number of BrdU+ cells significantly increases in the SGZ. At least 3 surviving animals were used for each experimental group. Data are expressed as
means ± SEM. Two-factor ANOVA:𝑁 = 3 to 5, ∗∗𝑝 < 0.01 and ∗∗∗𝑝 < 0.001, significantly different from iNOS+/+ saline; ###𝑝 < 0.001, significantly different
from iNOS−/− saline.
Saline SalineKA KA
3 days 3 days 7 days 7 days
iN
O
S−
/−
iN
O
S+
/+
Figure 3: Number of BrdU+ cells in the dentate gyrus increased with KA treatment. Representative images of BrdU+ cells (white), 3 and 7
days after KA or saline treatment in iNOS+/+ or iNOS−/− mice. Scale bar: 50 𝜇m.
Bonferroni’s test in GraphPad Prism 5 software. Differences
were considered significant when 𝑝 < 0.05.
3. Results and Discussion
3.1. NO Is Involved in the Proliferation of NSC in
the Dentate Gyrus following SE
3.1.1. Proliferation of Neural Stem Cells in the Hippocam-
pus following Seizures Comprises a NO-Dependent and NO-
Independent Phase. In order to investigate the role of NO
in cell proliferation, we used an in vivo KA-induced seizure
mouse model, as described in Section 2. Proliferation of
newborn cells was evaluated by the incorporation of BrdU, a
thymidine analogue. The number of BrdU+ cells in the den-
tate gyrus was assessed by immunohistochemistry (Figure 3).
In iNOS+/+ mice, treatment with KA increased signifi-
cantly the incorporation of BrdU in the SGZ from 3 days
after treatments up to 14 days, when compared to saline-
treated mice (Table 1, two-factor ANOVA; treatment: 31.95,
𝐹 = 151.5, 𝑑𝑓 = 3; time: 29.71, 𝐹 = 84.57, 𝑑𝑓 = 5; treatment
× time (interaction): 33.70, 𝐹 = 31.97, 𝑑𝑓 = 15), with a peak
at 5 days after treatment with KA (82.70 ± 5.87 cells/section,
𝑝 < 0.001). In iNOS+/+ mice treated with saline solution,
the number of BrdU+ cells did not change significantly
during the analyzed period of time (𝑝 > 0.05 for all time
points). These results are in line with previous findings that
seizures inmice trigger neuroinflammation and stimulate cell
proliferation in the SGZ of the dentate gyrus [11, 17, 19, 20].
Cell proliferation in the hippocampus is also increased in
different acute injured-animal models, such as stroke [21, 22]
and traumatic brain injury [23, 24].
In iNOS−/− mice, BrdU incorporation was unchanged
with KA treatment up to 5 days after seizures (7.73± 1.43 cells/
section at 1 day after SE (𝑝 > 0.05), 13.35 ± 3.87 cells/section
for 2 days after seizures (𝑝 > 0.05), 25.64 ± 0.53 cells/section
for 3 days after SE (𝑝 > 0.05), and 18.36 ± 1.99 cells/section
for 5 days after SE (𝑝 > 0.05)). Interestingly, the num-
ber of BrdU+ cells in the dentate gyrus of iNOS−/− mice
was significantly increased 7 days after seizures (87.08 ±
8.40 cells/section, 𝑝 < 0.001), compared with saline-treated
iNOS−/− mice (20.08 ± 0.61 cells/section). Finally, the incor-
poration of BrdU returned to basal levels 14 days after seizures
with KA treatment (27.33 ± 2.17 cells/section, 𝑝 > 0.05). In
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saline-treated iNOS−/− mice the incorporation of BrdU was
similar for all time points (𝑝 > 0.05). In these animals, prolif-
eration seems to be regulated by two different mechanisms:
one that is NO-dependent up to 5 days after seizures and
another that is regulated by a NO-independent mechanism,
at 7 days after seizures.
Production of inflammatory factors frommicroglia, such
as NO, has already been reported as essential for proliferation
of NSC in the hippocampus [25]. Our group previously
described the mechanism by which NO triggers the initial
proliferation in SVZ cells [15, 26]. In those studies, we
reported that NO is able to bypass the epidermal growth
factor receptor and directly activate upstream components of
ERK 1/2/MAPK signaling pathway, resulting in increased cell
proliferation of NSC in early stages [15].
Moreover, late proliferation depends on the activation
of cGMP and PKG, suggesting a biphasic mechanism of
proliferation trigged by NO [9]. Interestingly, we observed
an increase in proliferation of NSC 7 days after seizures in
iNOS−/−mice, which suggests that proliferation at this time is
independent of NO.There are some other potential signaling
pathways thatmay play a role inNSCproliferation at this time
point. For instance, the NO-cGMP pathway is an important
mediator of the proliferative effects of neuropeptide Y in
the hippocampus [27–29]. Also in a model of SE, activated
microglia induce the expression of insulin-like growth factor-
1 (IGF-1) and stimulates the proliferation of progenitor cells
in SGZ by a MAPK-dependent mechanism [30]. There are
several factors expressed by microglia cells that can regulate
neurogenesis and NSC can also regulate the activation of
microglia cells, so it is possible that this interactionmicroglia-
NSCmay function as some kind of compensatorymechanism
to regulate proliferation of NSC, independently of NO.
3.2. Involvement of NO on Migration and Distribution of
Newborn Cells in the Dentate Gyrus following Seizures
3.2.1. Distribution of Newborn Cells Formed 3 Days after
Seizures in the Dentate Gyrus Is Independent of NO. We next
investigated the role of NO in the distribution of newborn
cells in the dentate gyrus after 21 days following proliferation
dependent onNO (that occurs at 3 days post-seizure), to eval-
uatewhether the cells remained in the subgranular zone or are
redistributed to the outer layers of the dentate gyrus. iNOS+/+
or iNOS−/− mice were treated with either saline or KA and
BrdUwas injected in all animals 3 days later.The distribution
of the new cells formed at this time point was assessed in the
SGZ, IGZ, and OGZ of the dentate gyrus, 21 days after BrdU
administration. BrdU+ cells increased with KA treatment in
iNOS+/+ and iNOS−/− mice (Figure 4(a)). The total number
of BrdU+ cells significantly increased with KA treatment
in both iNOS+/+ and iNOS−/− mice (Figure 4(b), two-factor
ANOVA; genotype: 5.68, 𝐹 = 2.334, 𝑑𝑓 = 1, 𝑝 > 0.05;
treatment: 49.79, 𝐹 = 20.47, 𝑑𝑓 = 1, 𝑝 < 0.001; genotype ×
treatment (interaction): 0.76, 𝐹 = 0.3113, 𝑑𝑓 = 1, 𝑝 > 0.05).
For iNOS+/+ mice, treatment with KA duplicated BrdU+
cells (29.24 ± 2.91 BrdU+ cells/section, 𝑝 < 0.05) compared
to saline-treated mice (12.59 ± 1.66 BrdU+ cells/section).
For iNOS−/− mice, KA treatment also doubled the number
of BrdU+ cells (37.99 ± 7.75 BrdU+ cells/section, 𝑝 <
0.01) compared to saline-treatment (16.66 ± 2.89 BrdU+
cells/section).
In iNOS+/+ mice, KA treatment significantly increased
BrdU+ cells in SGZ (16.68 ± 1.56 BrdU+ cells/section, 𝑝 <
0.01) comparatively to saline-treatedmice (9.49 ± 1.18 BrdU+
cells/section) (Figure 4(c), two-factor ANOVA; treatment:
25.52, 𝐹 = 14.81, 𝑑𝑓 = 3, and 𝑝 < 0.001; regions: 41.85,
𝐹 = 36.43, 𝑑𝑓 = 2, and 𝑝 < 0.001; treatment × regions (inter-
action): 1.62, 𝐹 = 0.4690, 𝑑𝑓 = 6, and 𝑝 > 0.05). For these
mice, BrdU+ cells also increased with KA treatment in IGZ
(9.35 ± 1.97 BrdU+ cells/section, 𝑝 < 0.01) when compared
with saline-treated mice (2.48 ± 0.47 BrdU+ cells/section).
BrdU+ cells did not change significantly in OGZ with KA
treatment. Similarly, in iNOS−/− mice (Figure 4(c)), BrdU+
cells significantly increased after seizures in SGZ (17.98 ±
2.82 BrdU+ cells/section, 𝑝 < 0.05) and IGZ (12.37 ± 3.78
BrdU+ cells/section, 𝑝 < 0.05), compared with saline-treated
iNOS−/− mice. These results suggest that the distribution of
NSC born 3 days after the insult is regulated by a NO-inde-
pendent mechanism.
3.2.2. Abolishment of NODoes Not Affect Distribution of New-
born Cells Formed 21 Days following Seizures in the Dentate
Gyrus. We next investigated the role of NO in the distribu-
tion of newborn cells in the dentate gyrus after 21 days follow-
ing proliferation during a phase that is not dependent on NO
(that occurs at 7 days post-seizure). iNOS+/+ or iNOS−/−mice
were treated with either saline or KA, BrdU was injected in
all animals 7 days later, and perfusions performed 28 days
after BrdU injection (7 days after seizures followed by 21
days).
Treatment with KA in cells formed 7 days after seizures
did not change significantly the number of BrdU+ cells along
the dentate gyrus (21 days after the cells were labeled with
BrdU around day 7) for none of the genotypes (Figures 5(a)
and 5(b), two-factor ANOVA, treatment: 10.61, 𝐹 = 2.180,
𝑑𝑓 = 1, and 𝑝 > 0.05; genotype: 15.95, 𝐹 = 3.278, 𝑑𝑓 = 1,
and 𝑝 > 0.05; treatment × genotype (interaction): 0.45, 𝐹 =
0.09155, 𝑑𝑓 = 1, and 𝑝 > 0.05). In iNOS+/+ and iNOS−/−
mice, the number of BrdU+ cells in KA-treated mice was
similar in all zones of the dentate gyrus, compared to the
respective saline controls (Figure 5(c), two-factor ANOVA;
treatment: 11.25, 𝐹 = 4.592, 𝑑𝑓 = 3, and 𝑝 < 0.01; regions:
48.07, 𝐹 = 29.44, 𝑑𝑓 = 2, and 𝑝 < 0.001; treatment × regions
(interaction): 3.95, 𝐹 = 0.8072, 𝑑𝑓 = 6, and 𝑝 > 0.05).
According to our study, at 7 days after KA treatment
the proliferation of newborn cell is regulated by a NO-
independentmechanism. As described before, there are some
other factors that can lead to activation of signaling pathways
possible involved in regulation of proliferation of NSC in the
hippocampus at this stage of the neurogenesis. For instance,
IGF-1 produced by activated microglia cells can increase the
proliferation of NSC in the SGZ by a mechanism dependent
of the MAPK signaling [30]. Also there is the possibility of a
compensatory mechanism regulated by NSC, independently
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Figure 4: The number of BrdU+ cells in the dentate gyrus increased following seizures, 21 days after BrdU treatment, by a NO-independent
mechanism. (a) Representative images of the distribution of BrdU (green) and NeuN (red) positive cells in different layers of the dentate
gyrus of the hippocampus, 3 days after induction of seizures with KA or saline treatment, in iNOS+/+ and iNOS−/− mice. Scale bar: 20 𝜇m.
(b) Number of BrdU+ cells in iNOS+/+ and iNOS−/− mice. Data are expressed as means ± SEM. Two-factor ANOVA (Bonferroni’s posttest):
𝑁 = 5 to 7; ∗𝑝 < 0.05, significantly different from iNOS+/+ saline; ##𝑝 < 0.01, significantly different from iNOS−/− saline. (c) BrdU+ cells in
different layers of the dentate gyrus, namely, in the SGZ, IGZ and OGZ of iNOS+/+ vs iNOS−/− mice, 3 days following SE. Data are expressed
as means ± SEM. Two-factor ANOVA (Bonferroni’s posttest):𝑁 = 5 to 7; ∗∗𝑝 < 0.01, significantly different from iNOS+/+ saline; #𝑝 < 0.05,
significantly different from iNOS−/− saline.
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Figure 5: The number of BrdU+ cells in the dentate gyrus born 7 days after SE is not affected by NO, 21 days after treatment with BrdU.
(a) Representative images of BrdU (green) and NeuN (red) positive cells in the dentate gyrus, 7 days after treatment with KA or saline in
iNOS+/+ and iNOS−/− mice. Scale bar: 20 𝜇m. (b) Number of BrdU+ cells in iNOS+/+ and iNOS−/− mice. Data are expressed as means ± SEM.
Two-factor ANOVA (Bonferroni’s posttest),𝑁 = 4 to 6, 𝑝 > 0.05. (c) BrdU+ cells in the three regions of the dentate gyrus. Data are expressed
as means ± SEM. Two-factor ANOVA (Bonferroni’s posttest),𝑁 = 4 to 6, 𝑝 > 0.05.
of any other factor produced by microglia cells. Thus, the
distribution of newborn cells in the dentate gyrus was similar
in iNOS+/+ and iNOS−/− mice after seizures, suggesting that
NO is not involved in how cells are distributed along the
dentate gyrus 7 days after seizures, but other factors may be
involved.
3.3. NO Has Different Effects in Neuronal and
Astrocytic Differentiation
3.3.1. Early Neuronal Differentiation following Seizures Is
Dependent on NO. Here, we identified immature neurons
in iNOS+/+ and iNOS−/− mice treated with either saline or
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Figure 6: DCX immunoreactivity is dependent on NO, 14 days after seizures. (a) Representative images of DCX (white) immunoreactivity
in the dentate gyrus, 7 and 14 days after KA or saline treatment in iNOS+/+ and iNOS−/− mice. Scale bar: 100 𝜇m. (b) DCX-immunoreactive
area 7 days after SE. (c) DCX-immunoreactive area 14 days after SE. Data are expressed as means ± SEM. Two-factor ANOVA (Bonferroni’s
posttest):𝑁 = 3 to 6, ∗𝑝 < 0.05, significantly different from iNOS+/+ saline.
KA, as described in Section 2. DCX is a specific marker for
neuroblasts and immature neurons [31] born in the first two
weeks of the neurogenic process. Accordingly, we chose to
analyze DCX-immunoreactive area at 7 days and 14 days after
KA treatment.
TheDCX-immunoreactive areawas increased in iNOS+/+
mice, 14 days after seizures compared to saline-treated mice,
but not in KA-treated iNOS−/− compared to saline-treated
mice (Figure 6(a)). At 7 days after seizures, the percentage
of DCX-immunoreactive area tends to increase with KA
treatment in both iNOS+/+ (169.01 ± 33.50% of control, 𝑝 >
0.05) and iNOS−/− (145.64 ± 32.75% of control, 𝑝 > 0.05),
although this increase is not significant compared to saline-
treated mice (Figure 6(b), two-factor ANOVA; genotype:
0.79, 𝐹 = 0.1382, 𝑑𝑓 = 1, and 𝑝 > 0.05; treatment: 18.90,
𝐹 = 3.326, 𝑑𝑓 = 1, and 𝑝 > 0.05; genotype × treatment
(interaction): 0.78, 𝐹 = 0.1381, 𝑑𝑓 = 1, and 𝑝 > 0.05).
Later, at 14 days after seizures, the DCX+ area doubled in
iNOS+/+ mice (209.32 ± 4.07% of control, 𝑝 < 0.05), when
compared to saline-treatedmice of the same genotype (100.00
± 24.75%of control). In iNOS−/−mice, treatmentwithKAdid
not change the DCX-immunoreactive area (87.57 ± 5.48% of
control, 𝑝 > 0.05), at 14 days after seizures, when compared
with the saline-treated mice (100.00 ± 39.13). (Figure 6(c),
two-factor ANOVA; genotype: 23.01, 𝐹 = 6.420, 𝑑𝑓 = 1, and
𝑝 < 0.05; treatment: 14.57, 𝐹 = 4.065, 𝑑𝑓 = 1, and 𝑝 > 0.05;
genotype × treatment (interaction): 23.01, 𝐹 = 6.420, 𝑑𝑓 = 1,
and 𝑝 < 0.05).
Our results showed that NO from an inflammatory origin
increases the number of neuroblasts/immature neurons in
the dentate gyrus, at least at 2 weeks after seizures. It has
been shown that the number of DCX+ neuroblasts signifi-
cantly increased following treatment with L-NAME, a NOS
inhibitor, and KA together [32]. Moreover, in the same study,
inhibition of NOS alone increased the number of BrdU+
newborn cells in the hilus, which suggests a role for NO in
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Figure 7: NO decreases the number of newborn neurons born 3 days after seizures in iNOS+/+ mice. (a) Orthogonal projections of
representative images of BrdU-positive cells (BrdU+) shown green and NeuN-positive (NeuN+) cells, shown red. Scale bar: 20𝜇m.
Assessment of the percentage of BrdU-NeuN colocalizing cells in the dentate gyrus of iNOS+/+ or iNOS−/− mice, 3 days (b) or 7 days (c)
following SE. At least 3 surviving animals were used for each experimental group. Data are expressed as means ± SEM. Two-factor ANOVA
(Bonferroni’s posttest):𝑁 = 4 to 7; 𝑝 < 0.05, significantly different from iNOS+/+ saline.
their correct migration into the granular zone of the dentate
gyrus.
3.3.2. NO Limits Survival of the Cells That Proliferate Earlier
(3 Days) but Not Later (7 Days) after Seizures. To investigate
the survival at 21 days of cells formed 3 and 7 days after
seizures, colocalization of BrdU+/NeuN+-cells was assessed
by immunohistochemistry. NeuN is a neuronal marker for
mature neurons and colocalization with BrdU allows the
investigation of new neurons formed at the time point of
treatmentwith BrdU. Images of 50 BrdU+ cells of each animal
were acquired and orthogonal projections in 𝑦-axis were
performed for each image (Figure 7(a)).
At 21 days after treatment with BrdU, the percentage of
new neurons born 3 days after seizures decreased in iNOS+/+
mice treated with KA (53.50 ± 7.04% of BrdU+/NeuN+-cells,
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Figure 8: Absence of BrdU/Casp3 colocalization in cells formed 3 days after treatment with saline or KA in iNOS+/+ and iNOS−/− animals.
Representative images of BrdU-positive cells (red) and cleaved caspase-3 (Casp3, green). At least 3 surviving animals were used for each
experimental group. Scale bar: 20𝜇m.
𝑝 < 0.05), compared to saline-treated mice (72.29 ± 3.48%
of BrdU+/NeuN+-cells), but not in iNOS−/− mice (43.50 ±
6.95% of BrdU+/NeuN+-cells for saline and 43.20 ± 5.68%
of BrdU+/NeuN+-cells for KA-treated mice, 𝑝 > 0.05)
(Figure 7(b), two-factor ANOVA: genotype: 7.79, 𝐹 = 2.682,
𝑑𝑓 = 1, and 𝑝 > 0.05; treatment: 32.65, 𝐹 = 11.25, 𝑑𝑓 =
1, and 𝑝 < 0.01; genotype × treatment (interaction): 7.30,
𝐹 = 2.516, 𝑑𝑓 = 1, and 𝑝 > 0.05). These results suggest
that survival of newborn cells after seizures is regulated by a
NO-dependentmechanism, similar to proliferation ofNSC in
these conditions. However, NO seems to result in the forma-
tion of less new neurons after seizures.
NO may be toxic to neurons and neuronal apoptosis was
evident after administration of aNOdonor in a febrile seizure
rat model [33]. NO has also been proposed as an inhibitor of
cell-cycle progression in many cell types, through activation
of p53 or Rb signaling pathways [34, 35]. This relationship of
NO and programmed cell death might influence the survival
rate of the newborn cells. Moreover, NO does not necessarily
need to be directly toxic to newborn neurons but may be
involved in maintenance of inflammation that will condition
the survival of the new cells.
For neurons born 7 days after seizures, the number of
newneurons in iNOS+/+micewas very similar between treat-
ments, with 55.6 ± 7.22% of BrdU+/NeuN+-cells (𝑝 > 0.05)
inKA-treatedmice and 62.00± 5.03%of BrdU+/NeuN+-cells
for saline-treated mice. In iNOS−/− mice, treatment with KA
(69.50 ± 5.85% of BrdU+/NeuN+-cells) also did not change
the number of new neurons, compared to saline-treatedmice
(58.80 ± 8.31% of BrdU+/NeuN+-cells) (Figure 7(c), two-
factor ANOVA; genotype: 3.15, 𝐹 = 0.5348, 𝑑𝑓 = 1, and
𝑝 > 0.05; treatment: 0.53, 𝐹 = 0.09010, 𝑑𝑓 = 1, and 𝑝 > 0.05;
genotype × treatment (interaction): 8.07, 𝐹 = 1.372, 𝑑𝑓 = 1,
and 𝑝 < 0.05). These results suggest that cells that proliferate
in a NO-independent phase become neurons that survive
better than cells that proliferate earlier (3 days) after the onset
of seizures.
In order to confirm the effect of NO in survival of the cells
that proliferated 3 days after seizures, we assessed the colocal-
ization of BrdU with a cell death marker, cleaved caspase-3,
by immunohistochemistry. Representative images of each
animal were acquired (Figure 8). Colocalization of BrdUwith
cleaved caspase-3 was not observed, which suggests that
the decrease in the survival of the new neurons formed 3
days after seizures in iNOS+/+ animals does not result from
apoptosis of the proliferating cells at this time point (21 days
after treatmentwith BrdU). It is possible that cell death occurs
earlier or by other mechanisms.
3.3.3. Astrogliogenesis Is Not Affected by Abolishment of NO
after Seizures. We were interested in understanding whether
the proliferating cells could be differentiating into astrocytes.
In order to analyze this, we assessed GFAP+ cells formed 3
and 7 days after seizures by immunohistochemistry 21 days
after BrdU injection. GFAP is a protein expressed by astro-
cytes, and colocalization with BrdU allows the identification
of newborn astrocytes at the time point of treatment with
BrdU (Figure 9(a)).
In iNOS+/+ or in iNOS−/− mice, seizures did not change
the number of new astrocytes (BrdU-GFAP colocalizing
cells) 3 days following SE (3.50 ± 0.34%, 𝑝 > 0.05), compared
with saline-treated mice (2.71 ± 0.61%) (Figure 9(b), two-
factor ANOVA, genotype: 36.46, 𝐹 = 10.30, 𝑑𝑓 = 1, and
𝑝 < 0.01; treatment: 3.39, 𝐹 = 0.9584, 𝑑𝑓 = 1, and 𝑝 > 0.05;
genotype × treatment (interaction): 0.00, 𝐹 = 0.0005183,
𝑑𝑓 = 1, and 𝑝 > 0.05).
Furthermore, seizures did not change the number of
BrdU-GFAP colocalizing cells in both genotypes, 7 days after
SE (3.60 ± 0.51% or 2.75 ± 1.11% of BrdU-GFAP colocalizing
cells in iNOS+/+ mice or iNOS−/− mice, resp., 𝑝 > 0.05).
The percentage of BrdU-GFAP co-localizing cells in saline-
treated mice was very similar between iNOS+/+ and iNOS−/−
mice (2.00 ± 0.71% versus 1.20 ± 0.37%, resp.) (Figure 9(c),
two-factor ANOVA; genotype: 7.07, 𝐹 = 1.473, 𝑑𝑓 = 1, and
𝑝 > 0.05; treatment: 25.76, 𝐹 = 5.369, 𝑑𝑓 = 1, and 𝑝 < 0.05;
genotype × treatment (interaction): 0.01, 𝐹 = 0.001353, 𝑑𝑓 =
1, and 𝑝 > 0.05).
In vitro studies reported that exposure to pathological
levels of NO (0.1mM for 24 hours) promotes astroglial fate
determination in NSC over neuronal commitment or selec-
tively depletes early neuronal progenitor cells [36]. In this
particular model, astrogliogenesis seems to be positively
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Figure 9: Differentiation of newborn cells formed 3 and 7 days after SE into astrocytes is not affected by NO. (a) Orthogonal projections of
representative images of BrdU-GFAP colocalizing cells. Scale bar: 20𝜇m. Percentage of BrdU-GFAP colocalizing cells, 3 days (b) or 7 days
(c) following SE. Data are expressed as means ± SEM. Two-factor ANOVA (Bonferroni’s posttest),𝑁 = 4 to 7, 𝑝 > 0.05.
regulated by exposure to NO. Here we show that exposure
to NO originated from iNOS is not involved in astroglial
differentiation from neural stem cells after a brain injury,
which did not change per se the number of newborn GFAP+
cells.
3.4. NO Is Important for Astrogliosis in iNOS+/+ Mice 28 Days
after Treatment. Next, we evaluated the possible involvement
of NO in neuroinflammation, 28 days after seizures. For this
purpose, GFAP immunoreactivity was assessed by immuno-
histochemistry and the intensity of GFAP staining used as
a measure for astrogliosis (Figure 10(a)). In iNOS+/+ mice,
KA treatment increased GFAP immunoreactivity (170.45 ±
15.74% of control, 𝑝 < 0.05) when compared to saline-
treated mice (100.00 ± 23.87% of control), 28 days after
treatment (Figure 10(b), two-factor ANOVA, genotype: 28.27,
𝐹 = 6.721, 𝑑𝑓 = 1, and 𝑝 < 0.05; treatment: 6.41, 𝐹 = 1.527,
𝑑𝑓 = 1, and 𝑝 > 0.05; genotype × treatment (interaction):
6.42, 𝐹 = 1.527, 𝑑𝑓 = 1, and 𝑝 < 0.05). Here we show that
GFAP-immunoreactive area was increased 28 days after
seizures, in a NO-dependent manner, suggesting that neu-
roinflammation is still present at this time.
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Figure 10: Astrogliosis is affected by abolishment of NO, 28 days after seizures. (a) Representative images of GFAP (white) immunoreactivity
28 days after KA or saline treatment in iNOS+/+ or iNOS−/− mice. Scale bar: 100 𝜇m. (b) GFAP immunoreactivity 28 days following SE. Data
are expressed as means ± SEM. Two-factor ANOVA (Bonferroni’s posttest):𝑁 = 4 to 5; ∗𝑝 < 0.05, significantly different from iNOS+/+ saline.
Previously, our group studied neuroinflammation 5 days
after seizures and showed an increase in the number of reac-
tive astrocytes in either iNOS+/+ or iNOS−/− treated with KA;
thus the process is independent of NO production [15]. Here
we show that activation of astrocytes is maintained up to 28
days after seizures. However, the astrogliosis is not observed
at this time point in the mice lacking iNOS, suggesting that
late astrogliosis, but not early astrogliosis, is NO-dependent.
This prolonged neuroinflammation may condition survival
of the newborn neurons in iNOS+/+ KA-treated mice, as
observed.
3.5. Regulation of Physiological versus Pathophysiological Neu-
rogenesis by NO. The role of NO in regulation of neurogene-
sis is still unclear. Overall, NO seems to negatively regulate
neurogenesis in physiological conditions, while in patho-
physiological situations it shows proneurogenic action. Sev-
eral studies reported a decrease in proliferation of NSC [37–
39] and survival of the newborn cells [36]. NO can also mod-
ulate differentiation of newprecursors by increasing neuronal
[38, 39] or astrocytic differentiation [36].
After a brain insult, NO has been reported as proneu-
rogenic factor, since an increase in proliferation of NSC is
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reported in most of the injury-induced models, including
stroke and seizures [22, 40]. Although differentiation is
positively regulated by NO following brain insults [38], the
survival of the newborn cells seems to be decreased by NO
[41].
Our results, together with previous findings, suggest that
not only is proliferation of NSC regulated by NO-dependent
mechanisms following a lesion, but also differentiation and
survival of the newborn neurons are regulated by the pres-
ence of NO following seizures. The fact that NO is important
to maintain neuroinflammation up to 28 days after seizures
may have influence on survival of newborn cells and may
contribute to the failure of new neurons to efficiently survive
in such conditions.
4. Conclusions
With this work we aimed to understand the involvement of
NO produced from iNOS in hippocampal neurogenesis in
a status epilepticus mouse model. Our results showed that
production of NO in an inflammatory context increased
proliferation of the early-born NSC following a brain insult.
Early differentiation of neuroblasts and immature neurons
increased following seizures by aNO-dependentmechanism.
We also showed that the distribution of newborn cells along
the dentate gyrus was modified by seizures, but NO was not
involved in this phenomenon. Furthermore, survival of new
neurons formed at an early stage (3 days after seizures) is
decreased by NO. In fact, NO is showed to be important
in maintenance of neuroinflammation up to 28 days after
seizures, which may provide an aggressive environment for
the newborn cells, which fail to survive.
Altogether, these findings help to better understand the
involvement of NO produced by iNOS in different stages of
adult neurogenesis following injury and open the possibility
to explore new NO-based therapeutic approaches to brain
repair after an insult, knowing when NO is proneurogenic
and when it impairs survival of newborn neurons.
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